#METABOLOMICS WORKBENCH Kaori_20250611_192128 DATATRACK_ID:6029 STUDY_ID:ST003985 ANALYSIS_ID:AN006565 PROJECT_ID:PR002491 VERSION 1 CREATED_ON June 16, 2025, 11:23 pm #PROJECT PR:PROJECT_TITLE Glucose-activated JMJD1A drives visceral adipogenesis via PR:PROJECT_TITLE α-ketoglutarate-dependent chromatin remodeling PR:PROJECT_SUMMARY Understanding how extracellular glucose regulates adipose tissue remodeling is PR:PROJECT_SUMMARY key to decoding metabolic health. Here, we show that the histone demethylase PR:PROJECT_SUMMARY JMJD1A senses glucose availability via α-ketoglutarate (α-KG), a TCA cycle PR:PROJECT_SUMMARY metabolite derived from glycolysis. Upon glucose stimulation, α-KG accumulates PR:PROJECT_SUMMARY in the nucleus and activates JMJD1A to remove repressive H3K9me2 marks at PR:PROJECT_SUMMARY glycolytic and adipogenic gene loci, including Pparg. This initiates a PR:PROJECT_SUMMARY transcriptional feedforward loop that amplifies glycolysis and de novo PR:PROJECT_SUMMARY adipogenesis. Mechanistically, JMJD1A is pre-recruited to chromatin by NFIC, and PR:PROJECT_SUMMARY glucose-induced demethylation enables subsequent ChREBP binding. In vivo, mice PR:PROJECT_SUMMARY lacking JMJD1A in adipocyte precursors exhibit impaired adipose tissue PR:PROJECT_SUMMARY hyperplasia and compensatory hypertrophic expansion selectively in visceral fat, PR:PROJECT_SUMMARY resulting in metabolically unfavorable remodeling. These findings uncover a PR:PROJECT_SUMMARY glucose-sensing α-KG-JMJD1A pathway that regulates histone demethylation and de PR:PROJECT_SUMMARY novo adipogenesis, enabling adaptive expansion of visceral adipose tissue under PR:PROJECT_SUMMARY nutrient excess conditions. PR:INSTITUTE Tohoku University PR:LAST_NAME Sakai PR:FIRST_NAME Juro PR:ADDRESS 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan PR:EMAIL juro.sakai.b6@tohoku.ac.jp PR:PHONE +81-22-717-8117 #STUDY ST:STUDY_TITLE Glucose-activated JMJD1A drives visceral adipogenesis via ST:STUDY_TITLE α-ketoglutarate-dependent chromatin remodeling (Study part 6 of 5) ST:STUDY_SUMMARY Understanding how extracellular glucose regulates adipose tissue remodeling is ST:STUDY_SUMMARY key to decoding metabolic health. Here, we show that the histone demethylase ST:STUDY_SUMMARY JMJD1A senses glucose availability via α-ketoglutarate (α-KG), a TCA cycle ST:STUDY_SUMMARY metabolite derived from glycolysis. Upon glucose stimulation, α-KG accumulates ST:STUDY_SUMMARY in the nucleus and activates JMJD1A to remove repressive H3K9me2 marks at ST:STUDY_SUMMARY glycolytic and adipogenic gene loci, including Pparg. This initiates a ST:STUDY_SUMMARY transcriptional feedforward loop that amplifies glycolysis and de novo ST:STUDY_SUMMARY adipogenesis. Mechanistically, JMJD1A is pre-recruited to chromatin by NFIC, and ST:STUDY_SUMMARY glucose-induced demethylation enables subsequent ChREBP binding. In vivo, mice ST:STUDY_SUMMARY lacking JMJD1A in adipocyte precursors exhibit impaired adipose tissue ST:STUDY_SUMMARY hyperplasia and compensatory hypertrophic expansion selectively in visceral fat, ST:STUDY_SUMMARY resulting in metabolically unfavorable remodeling. These findings uncover a ST:STUDY_SUMMARY glucose-sensing α-KG-JMJD1A pathway that regulates histone demethylation and de ST:STUDY_SUMMARY novo adipogenesis, enabling adaptive expansion of visceral adipose tissue under ST:STUDY_SUMMARY nutrient excess conditions. ST:INSTITUTE Tohoku University ST:LAST_NAME Sakai ST:FIRST_NAME Juro ST:ADDRESS 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan ST:EMAIL juro.sakai.b6@tohoku.ac.jp ST:PHONE +81-22-717-8117 ST:STUDY_COMMENTS Figure S1H #SUBJECT SU:SUBJECT_TYPE Cultured cells SU:SUBJECT_SPECIES Mus musculus SU:TAXONOMY_ID 10090 #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS 6 3T3-L1_0h Sample source:3T3-L1 | Treatment:13C6-Glucose RAW_FILE_NAME(Anion)=6_d2.mzML; RAW_FILE_NAME(Cation)=6_d5.mzML; RAW_FILE_NAME(Glucose)=g6_d2-3.mzML SUBJECT_SAMPLE_FACTORS 7 3T3-L1_1h Sample source:3T3-L1 | Treatment:13C6-Glucose RAW_FILE_NAME(Anion)=7_d2.mzML; RAW_FILE_NAME(Cation)=7_d5.mzML; RAW_FILE_NAME(Glucose)=g7_d2-2.mzML SUBJECT_SAMPLE_FACTORS 8 3T3-L1_2h Sample source:3T3-L1 | Treatment:13C6-Glucose RAW_FILE_NAME(Anion)=8_d2.mzML; RAW_FILE_NAME(Cation)=8_d5.mzML; RAW_FILE_NAME(Glucose)=g8_d2.mzML SUBJECT_SAMPLE_FACTORS 9 3T3-L1_4h Sample source:3T3-L1 | Treatment:13C6-Glucose RAW_FILE_NAME(Anion)=9_d2.mzML; RAW_FILE_NAME(Cation)=9_d5.mzML; RAW_FILE_NAME(Glucose)=g9_d2.mzML #COLLECTION CO:COLLECTION_SUMMARY 3T3-L1 cells were washed twice with 5% mannitol before metabolite extraction. CO:COLLECTION_SUMMARY Aqueous metabolites were extracted with 400 µL of methanol containing three CO:COLLECTION_SUMMARY internal standards (3ISs; methionine sulfone, 2-(N-morpholino)ethanesulfonic CO:COLLECTION_SUMMARY acid [MES] and D-camphol-10-sulfonic acid [CSA]; 25 µM each) at room CO:COLLECTION_SUMMARY temperature for 10 min. Then 400 µL chloroform and 200 µL of water were added, CO:COLLECTION_SUMMARY and the solution was centrifuged at 10,000 × g for 3 min at 4ºC. The upper CO:COLLECTION_SUMMARY aqueous layer (400 µL) was filtered through a 5 kDa cutoff filter (Millipore), CO:COLLECTION_SUMMARY and the filtrate was stored at -80ºC until analysis. At the time of analysis, CO:COLLECTION_SUMMARY the filtrate was thawed and centrifugally concentrated and dissolved in 25 µL CO:COLLECTION_SUMMARY of water containing reference compounds (3-aminopyrrolidine and CO:COLLECTION_SUMMARY 1,3,5-benzenetricarboxylic acid; 200 µM each). CO:SAMPLE_TYPE Cultured cells #TREATMENT TR:TREATMENT_SUMMARY 3T3-L1 preadipocytes were differentiated with MDI mixture until day 4 and TR:TREATMENT_SUMMARY treated with 25 mM 13C glucose. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY For metabolite extraction, the 3T3-L1 cells were washed twice with ice-cold 5% SP:SAMPLEPREP_SUMMARY mannitol solution and covered with 1 mL of methanol containing 25 µM internal SP:SAMPLEPREP_SUMMARY standards for 10 min. 400 µL of the resulting extracts were mixed with 200 µL SP:SAMPLEPREP_SUMMARY of Milli-Q water and 400 µL of chloroform. 400 µL of the aqueous solution was SP:SAMPLEPREP_SUMMARY centrifugally filtered through a 5-kDa cut-off filter (Human Metabolome SP:SAMPLEPREP_SUMMARY Technologies, Tsuruoka, Japan) to remove proteins. The filtrate was SP:SAMPLEPREP_SUMMARY centrifugally concentrated and dissolved in 50 µL of Milli-Q water that SP:SAMPLEPREP_SUMMARY contained reference compounds (200 µM each of 3-aminopyrrolidine and trimesate) SP:SAMPLEPREP_SUMMARY immediately prior to metabolome analysis. #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE CE CH:INSTRUMENT_NAME Agilent 7100 CE CH:COLUMN_NAME Fused silica capillary i. d. 50 µm x 100 cm CH:SOLVENT_A 100% Water; 300 mM diethylamine CH:SOLVENT_B N/A CH:FLOW_GRADIENT N/A CH:FLOW_RATE N/A CH:COLUMN_TEMPERATURE N/A #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:INSTRUMENT_NAME Agilent 6410 QQQ MS:INSTRUMENT_TYPE Triple quadrupole MS:MS_TYPE ESI MS:ION_MODE NEGATIVE MS:MS_COMMENTS Agilent jet stream-ESI-MS/MS analysis was performed in negative ion mode using MS:MS_COMMENTS the following source parameters: dry gas temperature, 300°C; dry gas flow rate, MS:MS_COMMENTS 10 L/min; nebulizer pressure, 10 psi. Data were acquired using dynamic multiple MS:MS_COMMENTS reaction monitoring (MRM) mode, and the MRM transition setting was based on the MS:MS_COMMENTS in-house MRM library. Peaks were extracted using automatic integration software MS:MS_COMMENTS MasterHands (Keio University, Tsuruoka, Japan)(Sugimoto et al., Metabolomics, MS:MS_COMMENTS 2009). #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS fmol / cell MS_METABOLITE_DATA_START Samples 3T3-L1_0h 3T3-L1_1h 3T3-L1_2h 3T3-L1_4h Factors Sample source:3T3-L1 | Treatment:13C6-Glucose Sample source:3T3-L1 | Treatment:13C6-Glucose Sample source:3T3-L1 | Treatment:13C6-Glucose Sample source:3T3-L1 | Treatment:13C6-Glucose Glucose 0.67 0.14 0.16 0.15 Glucose (m+01) 0.020 N.D. N.D. N.D. Glucose (m+02) N.D. N.D. N.D. N.D. Glucose (m+04) N.D. N.D. N.D. N.D. Glucose (m+05) N.D. 0.031 0.089 0.043 Glucose (m+06) 0.005 1.1 1.3 0.81 MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name KEGG ID PubChem Glucose C00031 5793 Glucose (m+01) - - Glucose (m+02) - - Glucose (m+04) - - Glucose (m+05) - - Glucose (m+06) - - METABOLITES_END #END